Autologous cord blood <i>vs</i> individualized supplements in autistic spectrum disorder: CORDUS study results
ACB has superior efficacy to ICS in ASD; high inflammation, ferritin, age and body weight predict less improvement; more clinical studies are needed for studying ACB efficacy in ASD.
Authors
- Raluca Bogdan
- Felician Stancioiu (ORCID: https://orcid.org/0000-0001-8398-388X)
- Bogdan Ivanescu (ORCID: https://orcid.org/0000-0002-9184-0464)
- Radu Dumitrescu (ORCID: https://orcid.org/0009-0008-4481-394X)
Institutions
- Clinical Emergency Hospital Bucharest (RO)
- Institute for Diagnosis and Animal Health (RO)
Publication Details
- Journal
- World Journal of Clinical Pediatrics
- Published
- 2024-12-20
- DOI
- https://doi.org/10.5409/wjcp.v14.i1.96643
- Primary Topic
- Autism Spectrum Disorder Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00